top of page
Search

An Updated View of DHA Formulary Management

Our team recently published Part II in a 3-part series aimed at helping drug manufactures gain an updated view of VA and DOD drug management. We are grateful to Life Science Leader for their interest in the segment. The publication can be viewed on their digital platform at An Updated View of The Federal Segment: DHA Formulary Management. Highlights include:


  • The DOD Uniform Formulary is analogous to a commercial plan, with most expensive new market entrants being placed in the “non-formulary” tier 3 category. It’s important to remember that exclusion tier aside (Tier 4), the DOD formulary is essentially a three (3) tier drug management system. That means that the “branded” tier on DOD is akin to a preferred brand tier and the non-formulary tier is comparable to a commercial branded or specialty tier.



  • The DOD P&T Committee includes 20 voting members from DHA, Navy, Army, Airforce, Coast Guard, and TRICARE representing a variety of both healthcare operation functions and medical specialties as well as non-voting members, such as VA physicians or pharmacists, and invited guests such as other Federal Agencies to include Indian Health Services.


  • The majority of TRICARE For Life (TFL) enrollees do not generally subscribe to Medicare Part D and use the MHS for prescription fulfillment, providing a rich market for pharmacy benefit drug manufacturers.



For additional published thought-leadership by our consultants see:


 

bottom of page